21336312|oncogene|C0029016|start=18|end=26|GENE
21336312|induced|C0205263|start=27|end=34|CONC
21336312|dna damage response|C1155291|start=35|end=54|PHYS
21336312|heterochromatin|C0019397|start=59|end=74|ANAT
21336312|cancer|C0006826^C1547140^C1306459^C2707253|start=93|end=99|DISO^OCCU^PHYS
21336312|major|C0205164|start=105|end=110|CONC
21336312|mechanisms|C0441712|start=111|end=121|CONC
21336312|cellular senescence|C0007581|start=176|end=195|PHYS
21336312|activation|C1879547|start=201|end=211|ACTI
21336312|dna damage response|C1155291|start=219|end=238|PHYS
21336312|ddr|C1704844^C1333206|start=240|end=243|GENE
21336312|pathway|C1705987^C1704259|start=245|end=252|PHYS^CONC
21336312|formation|C0439634^C0220781^C1522492|start=261|end=270|PHEN^CONC
21336312|associated|C0332281|start=285|end=295|CONC
21336312|foci|C0205234|start=312|end=316|CONC
21336312|sahf|C3271467|start=318|end=322|ANAT
21336312|show|C1547282|start=333|end=337|CONC
21336312|fibroblasts|C1546634^C1550637^C0016030|start=352|end=363|CONC^ANAT
21336312|resistant to|C0332325|start=364|end=376|CONC
21336312|premature|C0205252|start=377|end=386|CONC
21336312|p16|C0525037|start=387|end=390|GENE
21336312|ink4a|C1705280^C0525037|start=391|end=396|GENE
21336312|induction|C0857127^C0205263|start=398|end=407|PROC^CONC
21336312|sahf|C3271467|start=409|end=413|ANAT
21336312|formed|C0205431|start=433|end=439|CONC
21336312|following|C0332282|start=440|end=449|CONC
21336312|oncogene activation|C1518575|start=450|end=469|DISO
21336312|detected|C1511790|start=482|end=490|PROC
21336312|cellular senescence|C0007581|start=510|end=529|PHYS
21336312|exposure to|C0332157|start=536|end=547|PHYS
21336312|variety|C2346866^C1883525|start=550|end=557|CONC
21336312|inducing|C0205263|start=572|end=580|CONC
21336312|stimuli|C0234402|start=581|end=588|PHEN
21336312|oncogene|C0029016|start=590|end=598|GENE
21336312|induced|C0205263|start=599|end=606|CONC
21336312|sahf formation|C3271468|start=607|end=621|PHYS
21336312|dna replication|C0598312^C2984261|start=633|end=648|PHYS^CONC
21336312|atr|C1427242^C1332120^C3540546^C1418580|start=653|end=656|GENE
21336312|ataxia telangiectasia|C0004135|start=658|end=679|DISO
21336312|related|C1552599^C1704787^C0439849|start=689|end=696|CONC
21336312|inactivation|C0544461|start=699|end=711|CONC
21336312|atm|C0004135^C0919524^C0678214|start=715|end=718|DISO^GENE^CONC
21336312|ataxia telangiectasia mutated|C0919524|start=720|end=749|GENE
21336312|p53|C0079419^C1705526|start=754|end=757|GENE
21336312|allows|C0683607|start=758|end=764|ACTI
21336312|proliferation|C0334094^C1514485|start=769|end=782|DISO^CONC
21336312|oncogene|C0029016|start=786|end=794|GENE
21336312|cells|C3282337^C0007634|start=806|end=811|ANAT
21336312|retain|C0333118|start=817|end=823|CONC
21336312|increased|C0442805^C0205217|start=824|end=833|CONC
21336312|heterochromatin|C0019397|start=834|end=849|ANAT
21336312|induction|C0857127^C0205263|start=850|end=859|PROC^CONC
21336312|cancers|C0006826|start=870|end=877|DISO
21336312|levels|C0441889|start=879|end=885|CONC
21336312|heterochromatin|C0019397|start=889|end=904|ANAT
21336312|normal|C1553402^C2698497^C1550457^C1553406^C1550469^C0205307^C1551394^C1704701^C1553399^C1553386|start=932|end=938|CONC
21336312|tissues|C0040300|start=939|end=946|ANAT
21336312|independent of|C0332291|start=956|end=970|CONC
21336312|proliferative index|C1514489|start=975|end=994|CONC
21336312|stage|C1306673^C1300072^C0205390|start=998|end=1003|PHYS^CONC
21336312|tumours|C0027651|start=1011|end=1018|DISO
21336312|pharmacological|C0205464^C0031330|start=1020|end=1035|OCCU^CONC
21336312|genetic|C0017296^C0314603|start=1040|end=1047|PROC^CONC
21336312|perturbation|C0332453|start=1048|end=1060|CONC
21336312|heterochromatin|C0019397|start=1064|end=1079|ANAT
21336312|oncogene|C0029016|start=1083|end=1091|GENE
21336312|cells|C3282337^C0007634|start=1103|end=1108|ANAT
21336312|increase|C0442805|start=1109|end=1117|CONC
21336312|ddr|C1704844^C1333206|start=1118|end=1121|GENE
21336312|signalling|C3537152|start=1122|end=1132|PHEN
21336312|lead|C1522538^C1704733^C3275067|start=1137|end=1141|PROC^DEVI^CONC
21336312|apoptosis|C0162638|start=1145|end=1154|PHYS
21336312|in vivo|C1515655|start=1156|end=1163|CONC
21336312|histone deacetylase inhibitor|C2266853|start=1167|end=1196|PHYS
21336312|causes|C0015127^C1314792|start=1205|end=1211|CONC
21336312|heterochromatin|C0019397|start=1212|end=1227|ANAT
21336312|relaxation|C0035028|start=1228|end=1238|ACTI
21336312|increased|C0442805^C0205217|start=1240|end=1249|CONC
21336312|ddr|C1704844^C1333206|start=1250|end=1253|GENE
21336312|apoptosis|C0162638|start=1255|end=1264|PHYS
21336312|tumour|C0027651|start=1269|end=1275|DISO
21336312|regression|C0684321^C0684320|start=1276|end=1286|DISO^PHYS
21336312|heterochromatin|C0019397|start=1316|end=1331|ANAT
21336312|induced|C0205263|start=1332|end=1339|CONC
21336312|ddr|C1704844^C1333206|start=1370|end=1373|GENE
21336312|suggest|C1705535|start=1378|end=1385|CONC
21336312|use of|C1524063|start=1395|end=1401|CONC
21336312|chromatin|C1325550|start=1402|end=1411|ANAT
21336312|drugs|C3687832|start=1422|end=1427|PROC
21336312|cancer therapies|C0920425|start=1431|end=1447|PROC
21336312|may|C3812381|start=1448|end=1451|CONC
21336312|benefit|C0814225|start=1452|end=1459|CONC
21336312|study|C0947630^C2603343^C0557651^C0008972^C1705923^C1880229|start=1469|end=1474|PROC^OBJC^CONC
21336312|chromatin|C1325550|start=1478|end=1487|ANAT
21336312|ddr|C1704844^C1333206|start=1492|end=1495|GENE
21336312|status|C0449438^C1546481|start=1496|end=1502|CONC
21336312|tumours|C0027651|start=1506|end=1513|DISO
